477 related articles for article (PubMed ID: 27816540)
1. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.
Mellon EA; Orman A; Joya LE; Montejo ME; Laronga C; Hoover SJ; Lee MC; Khakpour N; Kubal PF; Diaz R
Brachytherapy; 2017; 16(1):174-180. PubMed ID: 27816540
[TBL] [Abstract][Full Text] [Related]
2. Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
Schwartzberg BS; Chin DT; Dorn PL; Herron DS; Howell KT; Kemmis TJ; Miller SA; Moore JA; Paul D
Am J Surg; 2018 Oct; 216(4):689-693. PubMed ID: 30041733
[TBL] [Abstract][Full Text] [Related]
3. Initiation of an Intraoperative Radiotherapy Program at a Safety net Hospital: What Is the Impact of an Intraoperative Radiotherapy Program in Underserved Patients With Early Breast Cancer?
Lalchandani P; Sila C; Ozao-Choy J; Dauphine C
Am Surg; 2021 May; 87(5):833-838. PubMed ID: 33228433
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community.
Lorenzen AW; Kiriazov B; De Andrade JP; Lizarraga IM; Scott-Conner CE; Sugg SL; Erdahl LM; Sun W; Weigel RJ
Ann Surg Oncol; 2018 Oct; 25(10):3004-3010. PubMed ID: 30030731
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
[TBL] [Abstract][Full Text] [Related]
7. Factors predictive of failure to complete planned intraoperative breast radiation using the intrabeam® system.
Dossett LA; Abbott AM; Sun W; Loftus L; Lee MC; Diaz R; Laronga C
J Surg Oncol; 2016 Dec; 114(8):930-932. PubMed ID: 27861907
[TBL] [Abstract][Full Text] [Related]
8. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.
Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ
Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209
[TBL] [Abstract][Full Text] [Related]
9. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
[TBL] [Abstract][Full Text] [Related]
10. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Morra A; Lazzari R; Rotmensz N; Sangalli C; Luini A; Veronesi U; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):806-13. PubMed ID: 22245196
[TBL] [Abstract][Full Text] [Related]
11. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
Sawaki M; Miyamoto T; Fujisawa T; Itoh Y; Ebara T; Tachibana H; Kodaira T; Kikumori T; Yanagita Y; Iwata H
Ann Surg Oncol; 2019 Aug; 26(8):2428-2434. PubMed ID: 30993410
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[TBL] [Abstract][Full Text] [Related]
14. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
de Paula U; D'Angelillo RM; Andrulli AD; Apicella G; Caruso C; Ghini C; Gomellini S; Ponti E; Pompei M; Caccavari A; Petrocchi A; Costarelli L; Giordano M; La Pinta M; Meli EZ; Mauri M; Minelli M; Rossi R; Scavina P; Broglia L; Ponzani T; Loreti A; Fortunato L
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):678-687. PubMed ID: 33098960
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria.
Vanderwalde NA; Jones EL; Kimple RJ; Moore DT; Klauber-Demore N; Sartor CI; Ollila DW
Cancer; 2013 May; 119(9):1736-43. PubMed ID: 23361892
[TBL] [Abstract][Full Text] [Related]
17. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
[TBL] [Abstract][Full Text] [Related]
18. Recurrence rates for patients with early-stage breast cancer treated with IOERT at a community hospital per the ASTRO consensus statement for APBI.
Williams VL; Bhandari T; Chen LJ; Wagman LD; Carpenter M; Harness JK; Khanijou R; Gobran M; Olaya W; Carandang MI; Ash RB
Brachytherapy; 2019; 18(5):651-657. PubMed ID: 31235444
[TBL] [Abstract][Full Text] [Related]
19. Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience.
Brown A; Buss EJ; Chin C; Liu G; Lee S; Rao R; Taback B; Wiechmann L; Horowitz D; Choi JC; Katz LM; Connolly EP
Front Oncol; 2022; 12():788213. PubMed ID: 35847872
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
